VasocureĀ
The world's first drug to treat neointimal disease.Ā Vasocure is a clinical-stage nephrology therapeutics company with the world's first peptide to directly treat neointimal hyperplasia, or neointimal disease, arteriosclerosis, and atherosclerosis.
Behind the scenes
Video shoot and photography session at our New York City office.Ā
Ready to be understood?
Your technology is only as clear as the communication that represents it.
Book a 30-minute call
